Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript February 29, 2024
Puma Biotechnology, Inc. misses on earnings expectations. Reported EPS is $0.26 EPS, expectations were $0.37. Puma Biotechnology, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).
Operator: Good afternoon. My name is Alicia, and I’ll be your conference call operator today. At this time, all participants are in a listen-only mode....
